These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 37016296)

  • 1. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer.
    Li S; Xin K; Pan S; Wang Y; Zheng J; Li Z; Liu X; Liu B; Xu Z; Chen X
    Cell Mol Biol Lett; 2023 Apr; 28(1):28. PubMed ID: 37016296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Liquid Biopsy for Diagnosis of Bladder Cancer.
    Seok J; Kwak Y; Kim S; Kim EM; Kim A
    Int Neurourol J; 2024 Jun; 28(2):83-95. PubMed ID: 38956768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
    Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
    J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring.
    Lodewijk I; Dueñas M; Rubio C; Munera-Maravilla E; Segovia C; Bernardini A; Teijeira A; Paramio JM; Suárez-Cabrera C
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
    Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
    Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential clinical utility of liquid biopsies in ovarian cancer.
    Zhu JW; Charkhchi P; Akbari MR
    Mol Cancer; 2022 May; 21(1):114. PubMed ID: 35545786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer.
    Huang HM; Li HX
    Cancer Commun (Lond); 2021 Feb; 41(2):91-108. PubMed ID: 33377623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer.
    Freitas AJA; Causin RL; Varuzza MB; Calfa S; Hidalgo Filho CMT; Komoto TT; Souza CP; Marques MMC
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research Progress of Urine Biomarkers in the Diagnosis, Treatment, and Prognosis of Bladder Cancer.
    Jin F; Shahid M; Kim J
    Adv Exp Med Biol; 2021; 1306():61-80. PubMed ID: 33959906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
    Lopez-Beltran A; Cheng L; Gevaert T; Blanca A; Cimadamore A; Santoni M; Massari F; Scarpelli M; Raspollini MR; Montironi R
    Expert Rev Mol Diagn; 2020 Feb; 20(2):231-243. PubMed ID: 31795775
    [No Abstract]   [Full Text] [Related]  

  • 12. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 13. Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis.
    Karimi F; Azadbakht O; Veisi A; Sabaghan M; Owjfard M; Kharazinejad E; Dinarvand N
    Med Oncol; 2023 Aug; 40(9):265. PubMed ID: 37561363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsies for detection, surveillance, and prognosis of urothelial cancer: a future standard?
    Duquesne I; Abou Chakra M; Hage L; Pinar U; Loriot Y
    Expert Rev Anticancer Ther; 2023; 23(9):995-1007. PubMed ID: 37542214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes.
    Nagata M; Muto S; Horie S
    Dis Markers; 2016; 2016():8205836. PubMed ID: 26924873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine.
    Alberca-Del Arco F; Prieto-Cuadra D; Santos-Perez de la Blanca R; Sáez-Barranquero F; Matas-Rico E; Herrera-Imbroda B
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
    Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
    Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments.
    Lone SN; Nisar S; Masoodi T; Singh M; Rizwan A; Hashem S; El-Rifai W; Bedognetti D; Batra SK; Haris M; Bhat AA; Macha MA
    Mol Cancer; 2022 Mar; 21(1):79. PubMed ID: 35303879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
    Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
    Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy.
    Marrugo-Ramírez J; Mir M; Samitier J
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.